Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model

Untargeted Nuclear Magnetic Resonance (NMR) metabolomics of polar extracts from the pancreata of a caerulin-induced mouse model of pancreatitis (Pt) and of a transgenic mouse model of pancreatic cancer (PCa) were used to find metabolic markers of Pt and to characterize the metabolic changes accompan...

Full description

Bibliographic Details
Main Authors: Tatiana J. Carneiro, Joana Pinto, Eva M. Serrao, António S. Barros, Kevin M. Brindle, Ana M. Gil
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.937865/full
_version_ 1817998527350964224
author Tatiana J. Carneiro
Joana Pinto
Eva M. Serrao
Eva M. Serrao
António S. Barros
Kevin M. Brindle
Kevin M. Brindle
Ana M. Gil
author_facet Tatiana J. Carneiro
Joana Pinto
Eva M. Serrao
Eva M. Serrao
António S. Barros
Kevin M. Brindle
Kevin M. Brindle
Ana M. Gil
author_sort Tatiana J. Carneiro
collection DOAJ
description Untargeted Nuclear Magnetic Resonance (NMR) metabolomics of polar extracts from the pancreata of a caerulin-induced mouse model of pancreatitis (Pt) and of a transgenic mouse model of pancreatic cancer (PCa) were used to find metabolic markers of Pt and to characterize the metabolic changes accompanying PCa progression. Using multivariate analysis a 10-metabolite metabolic signature specific to Pt tissue was found to distinguish the benign condition from both normal tissue and precancerous tissue (low grade pancreatic intraepithelial neoplasia, PanIN, lesions). The mice pancreata showed significant changes in the progression from normal tissue, through low-grade and high-grade PanIN lesions to pancreatic ductal adenocarcinoma (PDA). These included increased lactate production, amino acid changes consistent with enhanced anaplerosis, decreased concentrations of intermediates in membrane biosynthesis (phosphocholine and phosphoethanolamine) and decreased glycosylated uridine phosphates, reflecting activation of the hexosamine biosynthesis pathway and protein glycosylation.
first_indexed 2024-04-14T02:54:26Z
format Article
id doaj.art-399346a3c6134faaadb8d2f0b107f229
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-04-14T02:54:26Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-399346a3c6134faaadb8d2f0b107f2292022-12-22T02:16:10ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2022-08-01910.3389/fmolb.2022.937865937865Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse modelTatiana J. Carneiro0Joana Pinto1Eva M. Serrao2Eva M. Serrao3António S. Barros4Kevin M. Brindle5Kevin M. Brindle6Ana M. Gil7CICECO - Aveiro Institute of Materials (CICECO/UA), Department of Chemistry, University of Aveiro, Aveiro, PortugalCICECO - Aveiro Institute of Materials (CICECO/UA), Department of Chemistry, University of Aveiro, Aveiro, PortugalCancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United KingdomDepartment of Biochemistry, University of Cambridge, Cambridge, United KingdomCICECO - Aveiro Institute of Materials (CICECO/UA), Department of Chemistry, University of Aveiro, Aveiro, PortugalCancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United KingdomDepartment of Biochemistry, University of Cambridge, Cambridge, United KingdomCICECO - Aveiro Institute of Materials (CICECO/UA), Department of Chemistry, University of Aveiro, Aveiro, PortugalUntargeted Nuclear Magnetic Resonance (NMR) metabolomics of polar extracts from the pancreata of a caerulin-induced mouse model of pancreatitis (Pt) and of a transgenic mouse model of pancreatic cancer (PCa) were used to find metabolic markers of Pt and to characterize the metabolic changes accompanying PCa progression. Using multivariate analysis a 10-metabolite metabolic signature specific to Pt tissue was found to distinguish the benign condition from both normal tissue and precancerous tissue (low grade pancreatic intraepithelial neoplasia, PanIN, lesions). The mice pancreata showed significant changes in the progression from normal tissue, through low-grade and high-grade PanIN lesions to pancreatic ductal adenocarcinoma (PDA). These included increased lactate production, amino acid changes consistent with enhanced anaplerosis, decreased concentrations of intermediates in membrane biosynthesis (phosphocholine and phosphoethanolamine) and decreased glycosylated uridine phosphates, reflecting activation of the hexosamine biosynthesis pathway and protein glycosylation.https://www.frontiersin.org/articles/10.3389/fmolb.2022.937865/fullpancreatitispancreatic cancerPanINpancreatic ductal adenocarcinomaKRASmetabolomics
spellingShingle Tatiana J. Carneiro
Joana Pinto
Eva M. Serrao
Eva M. Serrao
António S. Barros
Kevin M. Brindle
Kevin M. Brindle
Ana M. Gil
Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
Frontiers in Molecular Biosciences
pancreatitis
pancreatic cancer
PanIN
pancreatic ductal adenocarcinoma
KRAS
metabolomics
title Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
title_full Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
title_fullStr Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
title_full_unstemmed Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
title_short Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
title_sort metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant kras mouse model
topic pancreatitis
pancreatic cancer
PanIN
pancreatic ductal adenocarcinoma
KRAS
metabolomics
url https://www.frontiersin.org/articles/10.3389/fmolb.2022.937865/full
work_keys_str_mv AT tatianajcarneiro metabolicprofilingofinducedacutepancreatitisandpancreaticcancerprogressioninamutantkrasmousemodel
AT joanapinto metabolicprofilingofinducedacutepancreatitisandpancreaticcancerprogressioninamutantkrasmousemodel
AT evamserrao metabolicprofilingofinducedacutepancreatitisandpancreaticcancerprogressioninamutantkrasmousemodel
AT evamserrao metabolicprofilingofinducedacutepancreatitisandpancreaticcancerprogressioninamutantkrasmousemodel
AT antoniosbarros metabolicprofilingofinducedacutepancreatitisandpancreaticcancerprogressioninamutantkrasmousemodel
AT kevinmbrindle metabolicprofilingofinducedacutepancreatitisandpancreaticcancerprogressioninamutantkrasmousemodel
AT kevinmbrindle metabolicprofilingofinducedacutepancreatitisandpancreaticcancerprogressioninamutantkrasmousemodel
AT anamgil metabolicprofilingofinducedacutepancreatitisandpancreaticcancerprogressioninamutantkrasmousemodel